Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

NCT00022516 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1086

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Methotrexate

Sponsor

ETOP IBCSG Partners Foundation